Moreover, inhibition of RPE inflammation with Ruxolitinib, a JAK1/2 inhibitor, mitigated the severity of the aggressive, early-onset retina degeneration phenotype observed in Mertk knock out mice.
Glia enthusiast
FirstGen PhD. Latina in STEM 🇦🇷
Associate Research Scientist at YaleIBIO
PhD: Exactas_UBA
She/her